Lack of receptor activator of nuclear factor-κB ligand (RANKL) expression and functional production by human multiple myeloma cells

被引：0
|
作者：
Giuliani, M
Colla, S
Morandi, F
Barille-Nion, S
Rizzoli, V
机构：
[1] Univ Parma, Chair Hematol, I-43100 Parma, Italy
[2] Univ Parma, BMT Unit, I-43100 Parma, Italy
[3] INSERM, UMR 601, Nantes, France
来源：
HAEMATOLOGICA | 2005年 / 90卷 / 02期
关键词：
RANKL; multiple myeloma;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：275 / 278
页数：4
相关论文
共 50 条
  • [41] Circulating Receptor Activator of Nuclear Factor-κB (RANK), RANK ligand (RANKL), and Mammographic Density in Premenopausal Women
    Toriola, Adetunji T.
    Appleton, Catherine M.
    Zong, Xiaoyu
    Luo, Jingqin
    Weilbaecher, Katherine
    Tamimi, Rulla M.
    Colditz, Graham A.
    CANCER PREVENTION RESEARCH, 2018, 11 (12) : 789 - 796
  • [42] Evaluation of Isoflavones as Bone Resorption Inhibitors upon Interactions with Receptor Activator of Nuclear Factor-κB Ligand (RANKL)
    Zaklos-Szyda, Malgorzata
    Budryn, Grazyna
    Grzelczyk, Joanna
    Perez-Sanchez, Horacio
    Zyzelewicz, Dorota
    MOLECULES, 2020, 25 (01):
  • [43] Receptor activator of nuclear factor-?B ligand (RANKL) protects against hepatic ischemia/reperfusion injury in mice
    Sakai, Nozomu
    Van Sweringen, Heather L.
    Schuster, Rebecca
    Blanchard, John
    Burns, Justin M.
    Tevar, Amit D.
    Edwards, Michael J.
    Lentsch, Alex B.
    HEPATOLOGY, 2012, 55 (03) : 888 - 897
  • [44] Guggulsterone Inhibits Osteoclastogenesis Induced by Receptor Activator of Nuclear Factor-κB Ligand and by Tumor Cells by Suppressing Nuclear Factor-κB Activation
    不详
    CLINICAL CANCER RESEARCH, 2018, 24 (17) : 4347 - 4347
  • [45] Expression of receptor activator of nuclear factor-kappaB ligand (RANKL) in oral cancer cells.
    Iwamoto, T.
    Fukumoto, S.
    Yanamoto, S.
    Kawasaki, G.
    Yoshitomi, I.
    Mizuno, A.
    JOURNAL OF DENTAL RESEARCH, 2003, 82 : B161 - B161
  • [46] Histamine stimulates production of osteoclast differentiation factor/receptor activator of nuclear factor-κB ligand by osteoblasts
    Deyama, Y
    Kikuiri, T
    Ohnishi, G
    Feng, YG
    Takeyama, S
    Hatta, M
    Yoshimura, Y
    Suzuki, K
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2002, 298 (02) : 240 - 246
  • [47] Hedgehog signaling enhances core-binding factor a1 and receptor activator of nuclear factor-κB ligand (RANKL) gene expression in chondrocytes
    Takamoto, M
    Tsuji, K
    Yamashita, T
    Sasaki, H
    Yano, T
    Taketani, Y
    Komori, T
    Nifuji, A
    Noda, M
    JOURNAL OF ENDOCRINOLOGY, 2003, 177 (03) : 413 - 421
  • [48] Receptor activator of nuclear factor kappaB ligand (RANKL) and osteoprotegerin levels in multiple sclerosis
    Kurban, Sevil
    Akpinar, Zehra
    Mehmetoglu, Idris
    MULTIPLE SCLEROSIS, 2008, 14 (03): : 431 - 432
  • [49] Differential expression of receptor activator of nuclear factor-κB ligand and osteoprotegerin mRNA in periodontal diseases
    Bostanci, N.
    Ilgenli, T.
    Emingil, G.
    Afacan, B.
    Han, B.
    Toz, H.
    Berdeli, A.
    Atilla, G.
    McKay, I. J.
    Hughes, F. J.
    Belibasakis, G. N.
    JOURNAL OF PERIODONTAL RESEARCH, 2007, 42 (04) : 287 - 293
  • [50] Expression of receptor activator of nuclear factor κB ligand on bone marrow plasma cells correlates with osteolytic bone disease in patients with multiple myeloma
    Heider, U
    Langelotz, C
    Jakob, C
    Zavrski, I
    Fleissner, C
    Eucker, J
    Possinger, K
    Hofbauer, LC
    Sezer, O
    CLINICAL CANCER RESEARCH, 2003, 9 (04) : 1436 - 1440
12345